Back to results

University of Venda

Synthesis of Glitazone Analogues as Anti-Diabetic Drugs

Abstract

dc:description.abstract

In this study, three series of novel glitazones (acetates, glycinates and alaninates) were designed and prepared by using appropriate synthetic methods to incorporate aromatic ring, alicyclic amines and alanine moiety instead of glycine moiety as a linker via two carbons. This was done over five reaction steps. Compounds were synthesized using conventional methods from step one with nucleophilic substitution to Knoevenagel condensation reaction as the final step and were characterized by using a combination of 1H NMR, 13C NMR, IR spectroscopies as well as HRMS analysis. Fourteen final compounds were successfully obtained in good to excellent yields. Furthermore, the same compounds were subjected to in vitro screening for their inhibitory activities against α-glucosidase and α-amylase. Among all the synthesized compounds, 36f exhibited excellent antidiabetic activities against α-glucosidase. Compounds 36a, 36b, 36i and 36j also displayed good activities and have potential to be further investigated whereas compounds 36c, 36e, 36g and 36h exhibited moderated activities against α-glucosidase. Only compounds 36a, 36b, 36f, 36i and 36j displayed weak activities against α-amylase and the rest of the compounds were not active at all against α-amylase.

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Tshiluka, Ndivhuwo Raymond
Advisors dc:contributor.advisor
  • Mnyakeni - Moleele, S. S.
  • Ramaite, I D. I.

Subjects

dc:subject × 5

Rights

Language dc:language.iso
en

Identifiers

dc:identifier.*
Handle dc:identifier.uri
http://hdl.handle.net/11602/1250
OAI identifier oai:identifier
oai:univendspace.univen.ac.za:11602/1250

Chain of custody

source
Harvested from
University of Venda
Base URL
univendspace.univen.ac.za/server/oai/request
Last updated
2026-07-27
Source record
OAI-PMH GetRecord
citation

Tshiluka, Ndivhuwo Raymond. Synthesis of Glitazone Analogues as Anti-Diabetic Drugs. 2018. http://hdl.handle.net/11602/1250